Literature DB >> 21331528

Molecular mechanisms of PINK1-related neurodegeneration.

Joe H Pogson1, Rachael M Ivatt, Alexander J Whitworth.   

Abstract

PINK1 is a mitochondrially targeted kinase that has been linked to a rare monogenic form of Parkinson's disease (PD), a common neurodegenerative disease characterized by the degeneration of selected dopaminergic neurons. Intensive research using many model systems has clearly established a fundamental role for PINK1 in preventing mitochondrial dysfunction-a key mechanism long thought to play a central role in PD pathogenesis. Current hypotheses propose PINK1's important functions involve mitophagy, mitochondrial calcium buffering, and mitochondrial quality control. Furthermore, recent findings have revealed that PINK1's functions are likely regulated by a complex mechanism that includes regulated mitochondrial import and intramembrane proteolysis to influence its sub cellular and sub mitochondrial distribution. This review aims to summarize and evaluate recent findings, with particular emphasis on PINK1 localization, cleavage, and function in mitochondrial homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331528     DOI: 10.1007/s11910-011-0187-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  48 in total

1.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

2.  Mitofusin 2 tethers endoplasmic reticulum to mitochondria.

Authors:  Olga Martins de Brito; Luca Scorrano
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

3.  The kinase domain of mitochondrial PINK1 faces the cytoplasm.

Authors:  Chun Zhou; Yong Huang; Yufang Shao; Jessica May; Delphine Prou; Celine Perier; William Dauer; Eric A Schon; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

4.  Characterization of PINK1 processing, stability, and subcellular localization.

Authors:  William Lin; Un Jung Kang
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

5.  Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth.

Authors:  Julia Sämann; Jan Hegermann; Erika von Gromoff; Stefan Eimer; Ralf Baumeister; Enrico Schmidt
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

6.  Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin.

Authors:  Elena Ziviani; Ran N Tao; Alexander J Whitworth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

7.  Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

Authors:  Suzana Gispert; Filomena Ricciardi; Alexander Kurz; Mekhman Azizov; Hans-Hermann Hoepken; Dorothea Becker; Wolfgang Voos; Kristina Leuner; Walter E Müller; Alexei P Kudin; Wolfram S Kunz; Annabelle Zimmermann; Jochen Roeper; Dirk Wenzel; Marina Jendrach; Moisés García-Arencíbia; Javier Fernández-Ruiz; Leslie Huber; Hermann Rohrer; Miguel Barrera; Andreas S Reichert; Udo Rüb; Amy Chen; Robert L Nussbaum; Georg Auburger
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

8.  Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.

Authors:  Matthew E Gegg; J Mark Cooper; Kai-Yin Chau; Manuel Rojo; Anthony H V Schapira; Jan-Willem Taanman
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

9.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.

Authors:  Andreas Bender; Kim J Krishnan; Christopher M Morris; Geoffrey A Taylor; Amy K Reeve; Robert H Perry; Evelyn Jaros; Joshua S Hersheson; Joanne Betts; Thomas Klopstock; Robert W Taylor; Douglass M Turnbull
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

10.  PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.

Authors:  Alison Wood-Kaczmar; Sonia Gandhi; Zhi Yao; Andrey Y Abramov; Andrey S Y Abramov; Erik A Miljan; Gregory Keen; Lee Stanyer; Iain Hargreaves; Kristina Klupsch; Emma Deas; Julian Downward; Louise Mansfield; Parmjit Jat; Joanne Taylor; Simon Heales; Michael R Duchen; David Latchman; Sarah J Tabrizi; Nicholas W Wood
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  10 in total

1.  Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.

Authors:  Masahiro Iguchi; Yuki Kujuro; Kei Okatsu; Fumika Koyano; Hidetaka Kosako; Mayumi Kimura; Norihiro Suzuki; Shinichiro Uchiyama; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

2.  The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention.

Authors:  David J Bonda; Mark A Smith; George Perry; Hyoung-gon Lee; Xinglong Wang; Xiongwei Zhu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

3.  Microtubule affinity-regulating kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: effects on mitochondrial transport.

Authors:  Dorthe Matenia; Cindy Hempp; Thomas Timm; Annika Eikhof; Eva-Maria Mandelkow
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

Review 4.  Oxidative stress in genetic mouse models of Parkinson's disease.

Authors:  Mustafa Varçin; Eduard Bentea; Yvette Michotte; Sophie Sarre
Journal:  Oxid Med Cell Longev       Date:  2012-07-08       Impact factor: 6.543

Review 5.  Splicing: is there an alternative contribution to Parkinson's disease?

Authors:  Valentina La Cognata; Velia D'Agata; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2015-05-16       Impact factor: 2.660

Review 6.  Emerging modes of PINK1 signaling: another task for MARK2.

Authors:  Dorthe Matenia; Eva M Mandelkow
Journal:  Front Mol Neurosci       Date:  2014-05-08       Impact factor: 5.639

Review 7.  Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View.

Authors:  Roberta Filograna; Mariano Beltramini; Luigi Bubacco; Marco Bisaglia
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 8.  Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach.

Authors:  Valentina La Cognata; Giovanna Morello; Velia D'Agata; Sebastiano Cavallaro
Journal:  Hum Genet       Date:  2016-11-28       Impact factor: 4.132

9.  PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria.

Authors:  Kei Okatsu; Toshihiko Oka; Masahiro Iguchi; Kenji Imamura; Hidetaka Kosako; Naoki Tani; Mayumi Kimura; Etsu Go; Fumika Koyano; Manabu Funayama; Kahori Shiba-Fukushima; Shigeto Sato; Hideaki Shimizu; Yuko Fukunaga; Hisaaki Taniguchi; Masaaki Komatsu; Nobutaka Hattori; Katsuyoshi Mihara; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  miRNAs and their putative roles in the development and progression of Parkinson's disease.

Authors:  Garry Wong; Richard Nass
Journal:  Front Genet       Date:  2013-01-09       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.